Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Pharmadev SA currently has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This single pending action is being processed by 1 distinct examiner and is located within 1 distinct art unit. This indicates a specific and concentrated prosecution effort, with the company's current patent matter being reviewed by one individual within a single technical group at the patent office.
The busiest examiner for this portfolio is MERCIER, MELISSA S, who is assigned 1 busiest examiner pending office action. As the total volume of pending office actions for the company is 1, this examiner is responsible for the entire current workload. Consequently, the progress of the company's patent prosecution is currently dependent on the decisions and examination style of MERCIER, MELISSA S. Practitioners should note that with only 1 distinct examiner and 1 distinct art unit involved, the current prosecution landscape for Pharmadev SA is highly centralized.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MERCIER, MELISSA S | 1 | 72.1% | +5.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17614076 | METHOD FOR PREPARING PHARMACEUTICAL COMPOSITIONS CONTAINING AMPHIPHILIC ACTIVE INGREDIENTS | MERCIER, MELISSA S | 21d |
| Art Unit | Apps |
|---|---|
| 1615 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17614076 | METHOD FOR PREPARING PHARMACEUTICAL COMPOSITIONS CONTAINING AMPHIPHILIC ACTIVE INGREDIENTS | MERCIER, MELISSA S | 1615 | §102§103 | Final Rejection | 21d | Pending | Jul 11, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial